Research Interests
Non-Statin use in lowering LDL, Metabolic Syndrome, Familial Chylomicron Syndrome (FCS), Heterozygous Familial Hypercholesterolemia (HeFH), Advanced Genetic Lipid Disorders, Use of PCSK9 Inhibitors in the reduction of cardiac events
